Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast oral soluble film vs chewable tablet in children with asthma and allergic rhinitis
ChiCTR2500102694Phase 4Not yet recruiting
- Sponsor
- Jiangxi Provincial Children's Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of montelukast in asthma and allergic rhinitis (AR) (2 arms), sponsored by Jiangxi Provincial Children's Hospital. Primary endpoint: Child Respiratory and Asthma Control Score (TRACK) at 3 months. Planned start May 2025; status: not yet recruiting.
02
Drugs
montelukast
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on ChiCTR2500102694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102694.